J. Wedzicha and T. Seemungal, COPD exacerbations: defining their cause and prevention, The Lancet, vol.370, issue.9589, pp.786-96, 2007.
DOI : 10.1016/S0140-6736(07)61382-8

. Société-de-pneumologie-de-langue-française, Prise en charge de la BPCO : recommandations pour la pratique clinique, Rev Mal Respir, vol.27, issue.1, pp.1-76, 2010.

J. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova et al., Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.363, issue.12, pp.1128-1166, 2010.
DOI : 10.1056/NEJMoa0909883

C. Mathers and D. Loncar, Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Medicine, vol.52, issue.11, p.442, 2002.
DOI : 10.1371/journal.pmed.0030442.st007

J. Wedzicha, S. Brill, J. Allinson, and G. Donaldson, Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease, BMC Medicine, vol.143, issue.1, p.181, 2013.
DOI : 10.1378/chest.12-1489

J. Piquet, J. Chavaillon, P. David, F. Martin, F. Blanchon et al., High-risk patients following hospitalisation for an acute exacerbation of COPD, European Respiratory Journal, vol.42, issue.4, pp.946-55, 2013.
DOI : 10.1183/09031936.00180312

J. Wedzicha, Exacerbations, Chest, vol.121, issue.5, pp.136-177, 2002.
DOI : 10.1378/chest.121.5_suppl.136S

S. Sethi, N. Evans, B. Grant, and T. Murphy, New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.347, issue.7, pp.465-71, 2002.
DOI : 10.1056/NEJMoa012561

. Société-de-pneumologie-de-langue-française, Recommandations pour la prise en charge de la BPCO : antibiothérapie des exacerbations/décompensations, Rev Mal Respir, vol.20, pp.65-73, 2003.

T. Murphy, A. Brauer, K. Eschberger, P. Lobbins, L. Grove et al., Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease, Current Opinion in Pulmonary Medicine, vol.15, issue.2, pp.853-60, 2008.
DOI : 10.1097/MCP.0b013e328321861a

I. Tillie-leblond, C. Marquette, T. Perez, A. Scherpereel, C. Zanetti et al., Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors, Annals of Internal Medicine, vol.144, issue.6, pp.390-396, 2006.
DOI : 10.7326/0003-4819-144-6-200603210-00005

A. Cavailles, G. Brinchault-rabin, A. Dixmier, F. Goupil, C. Gut-gobert et al., Comorbidities of COPD, European Respiratory Review, vol.22, issue.130, pp.454-75, 2013.
DOI : 10.1183/09059180.00008612
URL : https://hal.archives-ouvertes.fr/hal-01099066

A. Agusti, L. Edwards, S. Rennard, W. Macnee, R. Tal-singer et al., Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype, PLoS ONE, vol.80, issue.5, p.37483, 2012.
DOI : 10.1371/journal.pone.0037483.s009

. Société-de-pneumologie-de-langue-française, Recommandations pour la prise en charge de la BPCO : Exacerbations : diagnostic, sévérité et prise en charge, Rev Mal Respir, vol.20, pp.56-64, 2003.

T. Wilkinson, G. Donaldson, J. Hurst, T. Seemungal, and J. Wedzicha, Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.169, issue.12, pp.1298-303, 2004.
DOI : 10.1164/rccm.200310-1443OC

J. Boe, J. Dennis, O. Driscoll, B. Bauer, T. Carone et al., European Respiratory Society Guidelines on the use of nebulizers, Eur Respir J, vol.18, pp.228-270, 2001.

N. Anthonisen, J. Manfreda, C. Warren, E. Hershfield, G. Harding et al., Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease, Annals of Internal Medicine, vol.106, issue.2, pp.196-204, 1987.
DOI : 10.7326/0003-4819-106-2-196

M. Miravitlles, F. Kruesmann, D. Haverstock, R. Perroncel, S. Choudhri et al., Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis, European Respiratory Journal, vol.39, issue.6, pp.1354-60, 2012.
DOI : 10.1183/09031936.00042111

W. Thompson, C. Nielson, P. Carvalho, N. Charan, and J. Crowley, Controlled trial of oral prednisone in outpatients with acute COPD exacerbation., American Journal of Respiratory and Critical Care Medicine, vol.154, issue.2, pp.407-419, 1996.
DOI : 10.1164/ajrccm.154.2.8756814

S. Aaron, K. Vandemheen, P. Hebert, R. Dales, I. Stiell et al., Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.348, issue.26, pp.2618-2643, 2003.
DOI : 10.1056/NEJMoa023161

A. Agusti, M. Carrera, F. Barbe, A. Munoz, and B. Togores, Oxygen therapy during exacerbations of chronic obstructive pulmonary disease, European Respiratory Journal, vol.14, issue.4, pp.934-943, 1999.
DOI : 10.1034/j.1399-3003.1999.14d34.x

E. Moloney, J. Kiely, and W. Mcnicholas, Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease, The Lancet, vol.357, issue.9255, pp.526-534, 2001.
DOI : 10.1016/S0140-6736(00)04049-6

D. Mccrory and C. Brown, Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, p.3900, 2002.

D. Niewoehner, M. Erbland, R. Deupree, D. Collins, N. Gross et al., Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.340, issue.25, pp.1941-1948, 1999.
DOI : 10.1056/NEJM199906243402502

L. Davies, R. Angus, and P. Calverley, Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial, The Lancet, vol.354, issue.9177, pp.456-60, 1999.
DOI : 10.1016/S0140-6736(98)11326-0

J. Leuppi, P. Schuetz, R. Bingisser, M. Bodmer, M. Briel et al., Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease, JAMA, vol.309, issue.21, pp.2223-2254, 2013.
DOI : 10.1001/jama.2013.5023

A. Sullivan, C. Edlund, and C. Nord, Effect of antimicrobial agents on the ecological balance of human microflora. The Lancet infectious diseases, pp.101-115, 2001.

B. Fantin, X. Duval, L. Massias, L. Alavoine, F. Chau et al., Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria, The Journal of Infectious Diseases, vol.200, issue.3, pp.390-398, 2009.
DOI : 10.1086/600122
URL : https://hal.archives-ouvertes.fr/inserm-00409776

D. Chen, A. Mcgeer, J. De-azavedo, and D. Low, to Fluoroquinolones in Canada, New England Journal of Medicine, vol.341, issue.4, pp.233-242, 1999.
DOI : 10.1056/NEJM199907223410403

C. Garcia-vidal, P. Almagro, V. Romani, M. Rodriguez-carballeira, E. Cuchi et al., Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study, European Respiratory Journal, vol.34, issue.5, pp.1072-1080, 2009.
DOI : 10.1183/09031936.00003309

S. Lin, P. Kuo, P. Hsueh, P. Yang, and S. Kuo, Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa, Respirology, vol.152, issue.1, pp.81-88, 2007.
DOI : 10.1111/j.1600-0463.2005.apm1130203.x

M. Christ-crain, D. Jaccard-stolz, R. Bingisser, M. Gencay, P. Huber et al., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, The Lancet, vol.363, issue.9409, pp.600-607, 2004.
DOI : 10.1016/S0140-6736(04)15591-8

D. Stolz, M. Christ-crain, R. Bingisser, J. Leuppi, D. Miedinger et al., Antibiotic Treatment of Exacerbations of COPD, Chest, vol.131, issue.1, pp.9-19, 2007.
DOI : 10.1378/chest.06-1500

C. Burtin, M. Decramer, R. Gosselink, W. Janssens, and T. Troosters, Rehabilitation and acute exacerbations, European Respiratory Journal, vol.38, issue.3, pp.702-714, 2011.
DOI : 10.1183/09031936.00079111
URL : http://erj.ersjournals.com/content/erj/38/3/702.full.pdf

S. Keenan, T. Sinuff, D. Cook, and N. Hill, Which Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Benefit from Noninvasive Positive-Pressure Ventilation?, Annals of Internal Medicine, vol.138, issue.11, pp.861-70, 2003.
DOI : 10.7326/0003-4819-138-11-200306030-00007

L. Brochard, Mechanical ventilation: invasive versus noninvasive. The European respiratory journal Supplement, pp.31-38, 2003.
DOI : 10.1183/09031936.03.00050403

S. Française-d and N. Aiguë, Anesthésie-Réanimation (SFAR) Société de Pneumologie de Langue Française (SPLF) et la Société de Réanimation de Langue Française (SRLF), CONFERENCE DE CONSENSUS, 2006.

F. Ram, J. Wedzicha, J. Wright, and M. Greenstone, Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence, BMJ, vol.329, issue.7461, p.315, 2004.
DOI : 10.1136/bmj.38159.650347.55

E. Jeppesen, K. Brurberg, G. Vist, J. Wedzicha, J. Wright et al., Hospital at home for acute exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.274, issue.1, p.3573, 2012.
DOI : 10.1002/14651858.CD003573.pub2

S. Alrajab, T. Smith, M. Owens, J. Areno, and G. Caldito, A Home Telemonitoring Program Reduced Exacerbation and Healthcare Utilization Rates in COPD Patients with Frequent Exacerbations, Telemedicine and e-Health, vol.18, issue.10
DOI : 10.1089/tmj.2012.0005

C. Pedone, D. Chiurco, S. Scarlata, and R. Incalzi, Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial. BMC health services research, p.82, 2013.

S. Calvo, G. Gomez-suarez, C. Soriano, J. Zamora, E. Gonzalez-gamarra et al., A home telehealth program for patients with severe COPD: The PROMETE study. Respiratory medicine, 2013.

H. Pinnock, J. Hanley, L. Mccloughan, A. Todd, A. Krishan et al., Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial, BMJ, vol.347, issue.oct17 3, p.6070, 2013.
DOI : 10.1136/bmj.f6070

N. Roche, Position de la Soci??t?? de pneumologie de langue fran??aise vis-??-vis de la version 2011??des recommandations GOLD, Revue des Maladies Respiratoires, vol.29, issue.5, pp.637-646, 2012.
DOI : 10.1016/j.rmr.2012.05.012